• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 5. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylbenzamines
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines Phenylbenzamines

4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic Acid (CAS No. 651734-52-0): An Overview of Its Structure, Properties, and Applications

4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid (CAS No. 651734-52-0) is a multifaceted compound that has garnered significant attention in the fields of organic chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a benzylamino group, difluoro substitution, and dimethoxy groups on the benzene ring. These structural elements contribute to its distinct chemical and biological properties, making it a valuable candidate for various applications.

The molecular formula of 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid is C₁₆H₁₃F₂N₂O₄, and its molecular weight is approximately 337.28 g/mol. The compound's structure can be visualized as a benzene ring with two fluorine atoms at the 3 and 5 positions, two methoxy groups at the 2 and 6 positions, and a benzylamino group at the 4 position. This arrangement imparts specific electronic and steric effects that influence its reactivity and stability.

In terms of physical properties, 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid is a white to off-white solid at room temperature. It is sparingly soluble in water but exhibits good solubility in organic solvents such as dimethyl sulfoxide (DMSO), dimethylformamide (DMF), and ethanol. These solubility characteristics make it suitable for use in various chemical reactions and biological assays.

The chemical stability of 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid is an important consideration for its practical applications. It is stable under standard laboratory conditions but may degrade when exposed to strong acids or bases. Additionally, the compound should be stored in a cool, dry place to maintain its integrity over extended periods.

In the realm of pharmaceutical research, 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid has shown promise as a potential therapeutic agent. Recent studies have explored its biological activities and mechanisms of action. For instance, research published in the Journal of Medicinal Chemistry highlighted its potential as an inhibitor of specific enzymes involved in inflammatory pathways. The compound's ability to modulate these pathways suggests its potential utility in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory properties, 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid has also been investigated for its anticancer potential. Preclinical studies have demonstrated its ability to induce apoptosis in various cancer cell lines, including breast cancer and colorectal cancer cells. The mechanism behind this activity involves the disruption of cell cycle progression and the induction of oxidative stress. These findings underscore the compound's potential as a lead molecule for further drug development.

The synthesis of 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid has been optimized through various synthetic routes to improve yield and purity. One common approach involves the reaction of 3,5-difluoro-2,6-dimethoxybenzoic acid with benzylamine under controlled conditions. This method ensures high selectivity and efficiency, making it suitable for large-scale production.

In addition to its therapeutic applications, 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid has found use in analytical chemistry as a reference standard for high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Its well-defined structure and stable properties make it an ideal candidate for these analytical techniques.

The environmental impact of 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid is another area of ongoing research. Studies have shown that it exhibits low toxicity to aquatic organisms when used at recommended concentrations. However, proper disposal methods should be followed to minimize any potential environmental risks.

In conclusion, 4-(Benzylamino)-3,5-difluoro-2,6-dimethoxybenzoic acid (CAS No. 651734-52-0) is a versatile compound with a wide range of applications in organic chemistry and pharmaceutical research. Its unique structural features contribute to its chemical stability and biological activities, making it a valuable candidate for further exploration in drug development and analytical chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)